Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 96
Filtrar
1.
Rev. cuba. med. gen. integr ; 38(2): e1689, abr.-jun. 2022. tab
Artículo en Español | LILACS, CUMED | ID: biblio-1408705

RESUMEN

Introducción: La bronquiolitis aguda es la infección del tracto respiratorio inferior más frecuente en el lactante. Tiene una incidencia anual del 10 por ciento en los lactantes y una tasa de ingreso de entre el 2 y el 5 por ciento con un incremento importante en los últimos años. Objetivo: Determinar la efectividad del uso de solución salina hipertónica al 3 por ciento nebulizada en pacientes con bronquiolitis aguda. Métodos: Se realizó un estudio analítico longitudinal prospectivo de tipo casos y controles. El universo estuvo constituido por 132 pacientes distribuidos en 66 casos y 66 controles. Resultados: La edad media fue de 3,6 ± 2,5 meses. Los sibilantes se hallaron en 129 pacientes, lo que representó el 97,7 por ciento. Se encontró una estadía hospitalaria media de 3,19 ± 1,41 días en los casos, mientras que en los controles se encontró una media de 4,97 ± 1,77 días, diferencia que resultó altamente significativa (p < 0,001). Conclusiones: Aunque los pacientes tratados con solución salina hipertónica al 3 por ciento necesitaron más días con oxigenoterapia, el tratamiento resultó ser efectivo al mostrar una menor estadía hospitalaria y un menor número de complicaciones en pacientes con bronquiolitis aguda(AU)


Introduction: Acute bronchiolitis is the most frequent lower respiratory tract infection in the infant. It has a yearly incidence of 10 percent in infants and an admission rate of 2 percent to 5 percent, with a significant increase in recent years. Objective: To determine the effectiveness of nebulized 3 percent hypertonic saline solution treatment in patients with acute bronchiolitis. Methods: A prospective, longitudinal and analytical study of case-control design was carried out. The universe consisted of 132 patients distributed into 66 cases and 66 controls. Results: The mean age was 3.6±2.5 months. Wheezing was found in 129 patients, accounting for 97.7 percent. A mean hospital stays of 3.19±1.41 days was found in cases, while a mean of 4.97±1.77 days was found in controls, a difference that was highly significant (P<0.001). Conclusions: Although patients treated with 3 percent hypertonic saline solution required more days with oxygen therapy, the treatment proved to be effective by showing a shorter hospital stay and a lower number of complications in patients with acute bronchiolitis(AU)


Asunto(s)
Humanos , Masculino , Femenino , Preescolar , Niño , Bronquiolitis Viral/epidemiología , Solución Salina Hipertónica/uso terapéutico , Estudios Prospectivos , Estudios Longitudinales
2.
Acta pediátr. hondu ; 12(1): 1222-1230, abr.-sep. 2021. graf., tab.
Artículo en Español | LILACS, BIMENA | ID: biblio-1372395

RESUMEN

Antecedentes: La bronquiolitis es una enfermedad viral aguda del tracto respiratorio inferior en niños menores de dos años, con una tasa máxima de aparición entre 2-10 meses de edad. Objetivo: Evaluar eficacia y seguridad de solución salina hipertónica nebulizada con o sin epinefrina en el manejo de la bronquiolitis aguda. Materiales y métodos:Estudio cuasi-experimental longitudinal, en lactantes ingresados en Hospital Nacional Mario Catarino Rivas (HNMCR), con bronquiolitis aguda leve. Se analizaron 26 casos, asignados al azar, 12 recibieron nebulizaciones con solución salina hipertónica al 3% mas 1 ml de epinefrina (SSH+E) y 14 recibieron 3 ml de solución hipertónica al 3% (SSH), administrados cada 4 horas, y se realizaron análisis de la Escala de Wood Downes- Ferres, saturación de oxígeno y complicaciones posteriores a las nebulizaciones cada 6 horas, por un periodo de 24 horas. El estudio fue aprobado por un comité de ética. Resultados: La estancia hospitalaria se redujo significativamente en el grupo de SSH en comparación con el grupo SSH+E (1,79±0,80 días: 2,50±0,79 días, P = 0,032). El score clínico disminuyo en ambos grupos, pero no hubo diferencia estadísticamente significativa (p=0,187 vs p=0,074, al llegar y luego de 24 horas) Las complicaciones encontradas fueron estadísticamente significativas para el grupo de SSH+E, posterior a las primeras 3 nebulizaciones P = 0,007 y a las 12 horas P = 0,019. Conclusión: Las nebulizaciones con SSH y con SSH+E son igualmente eficaces, sin embargo, la SSH demostró mayor seguridad y acortó significativamente la estancia hospitalaria de los lactantes hospitalizados con bronquiolitis aguda leve...(AU)


Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Solución Salina Hipertónica/uso terapéutico , Bronquitis/diagnóstico , Infecciones del Sistema Respiratorio/complicaciones
3.
Pesqui. vet. bras ; 37(9): 963-970, Sept. 2017. tab, ilus
Artículo en Portugués | LILACS, VETINDEX | ID: biblio-895525

RESUMEN

Na clínica de animais de companhia é frequente cães com síndrome da diarreia hemorrágica aguda associada a quadros de sepse, o que acarreta alta mortalidade. Nesse contexto, objetivou-se, em um ensaio clínico controlado aleatorizado de centro único, estudar os efeitos tardios da solução salina hipertônica a 7,5% em aplicações seriadas, sobre variáveis hemodinâmicas, clínicas e laboratoriais em cães com quadro de sepse grave decorrente desta síndrome. Para tal, 12 cães foram aleatoriamente distribuídos em dois grupos de igual número, sendo um controle (CON) e o outro, solução salina hipertônica 7,5% (SSH). Variáveis clínicas e laboratoriais foram avaliadas imediatamente após a admissão do paciente (T0), 24 (T24), 48 (T48) e 72 (T72) horas após a admissão. O grupo SSH recebeu Ringer com lactato, antibioticoterapia, analgésico e SSH 7,5% em bolus (5mL kg-1 em 4 minutos) no T24 e no T48. O grupo CON recebeu a mesma terapia acima, porém ao invés da utilização de SSH a 7,5%, administrou-se bolus de solução de Ringer lactato na mesma dose e tempos utilizado. As avaliações em cada tempo foram realizadas anteriormente à administração dos bolus, nos dois grupos. Avaliaram-se hemograma completo e as variáveis clínicas (escala AVDN, grau de desidratação, frequência respiratória e temperatura retal), frequência cardíaca (FC), pressão arterial sistólica (PAS). Os dados paramétricos foram avaliados pelos testes Student Newman Keuls e teste t de Student, e os não paramétricos pelo teste de Friedman e Mann Whitney, com nível de significância de P≥0,05. Nas variáveis clínicas estudadas não se observou diferença entre os grupos e entre os momentos avaliados. Observou-se diferença significativa no grupo SSH no T72, com elevação da PAS e redução da FC, fato não observado no grupo CON, onde esses parâmetros não se alteraram. O hematócrito e a concentração de hemoglobina diminuíram em ambos os grupos com o tempo. As contagens dos leucócitos totais e dos monócitos apresentaram uma elevação significativa no grupo SSH, estando os leucócitos dentro da faixa de normalidade no T72. Não houve diferenças significativas em relação aos neutrófilos segmentados, porém no grupo SSH verificou-se aumento de 9,5 vezes no T72 comparado com o T24 (P=0,09), enquanto que este aumento foi de apenas 2,5 vezes no grupo CON (P=0,30). Observou-se ainda redução nas contagens de plaquetas e na concentração de globulinas no grupo COM, enquanto essas variáveis se mantiveram estáveis no grupo SSH. Conclui-se que a administração seriada de SSH 7,5% se mostrou promissora no tratamento de cães com síndrome da diarreia hemorrágica aguda, pois auxilia na estabilização dos leucócitos, plaquetas e globulinas de cães com sepse grave decorrente da síndrome da diarreia hemorrágica aguda.(AU)


The association between acute hemorrhagic diarrhea syndrome and sepsis is frequent in dogs and causes high mortality. In this context we investigated in a randomized single-center controlled trial the late effects of 7.5% hypertonic saline solution in serial applications on hemodynamic, clinical and laboratory variables in dogs with severe sepsis due to the syndrome. Twelve dogs were randomly distributed into two groups of equal numbers, control (CON) and 7.5% hypertonic saline solution (SSH). Clinical and laboratory variables were evaluated immediately after admission of patients (T0), 24 (T24), 48 (T48) and 72 (T72) hours after the admission. The SSH group received Ringer with lactate, antibiotic therapy, analgesic and 5mL/kg-1 bolus of 7.5% SSH over 4 minutes on T24 and T48. The CON group received the same therapy, but instead of 7.5% SSH, Ringer with lactate bolus was given at the same dosis and times. All evaluations were performed prior to the administration of the bolus in both groups. Data collection included complete blood count and clinical variables (AVDN scale, degree of dehydration, respiratory rate and rectal temperature), heart rate (HR) and systolic blood pressure (SBP). Parametric data were evaluated by the Student Newman Keuls and Student t tests, and the nonparametric ones by the Friedman and Mann Whitney test, with a significance level of 0.05. There were no significant differences between the groups and moments in clinical variables. Nevertheless, the SSH group presented a significant elevation of SBP and HR reduction at T72. Hematocrit and hemoglobin concentration decreased in both groups over time. Total leukocyte and monocyte counts showed a significant elevation in the SSH group, however the leukocytes were within the normal range at T72. There were no significant differences in the segmental neutrophils, but a 9.5-fold increase in T72 compared to T24 (P=0.09) in the SSH group was observed, whereas this increase was only 2.5-fold in the CON group (P=0.30). A decrease in platelet counts and globulin concentration was observed in the CON group, while these variables remained stable in the SSH group. In conclusion, serial administration of 7.5% SSH is promising in the therapy of dogs with acute hemorrhagic diarrhea syndrome, since it assists in the stabilization of leukocytes, platelets and globulins in dogs with severe sepsis due to this syndrome.(AU)


Asunto(s)
Animales , Perros , Solución Salina Hipertónica/administración & dosificación , Solución Salina Hipertónica/uso terapéutico , Sepsis/veterinaria , Disentería/veterinaria
4.
Medical Principles and Practice. 2017; 26 (3): 292-295
en Inglés | IMEMR | ID: emr-188538

RESUMEN

Objective:To present a case with 4 different potential causes of hyponatremia


Clinical Presentation and Intervention: The patient presented with the following symptoms: nausea, vomiting, diarrhea, and dark urine after drinking large amounts of fluids that included alcohol and caffeine. Laboratory, microbiological, and morphological examinations revealed the existence of severe hyponatremia and acute poststreptococcal glomerulonephritis. The patient developed acute symptomatic seizures and coma. Gradual normalization of the sodium level led to a recovery of consciousness


Conclusion:Treatment with hypertonic sodium, fluid restriction, and antibiotics led to a complete recovery. In the case of multiple causes of hyponatremia, it is necessary to treat all causes


Asunto(s)
Humanos , Masculino , Adulto , Glomerulonefritis/complicaciones , Convulsiones/etiología , Coma/etiología , Sodio/deficiencia , Solución Salina Hipertónica/uso terapéutico
5.
Rev. méd. Minas Gerais ; 26(supl. 2): 23-25, 2016. tab
Artículo en Portugués | LILACS | ID: biblio-882365

RESUMEN

Bronquiolite viral aguda consiste em uma afecção viral que acomete lactentes com idade inferior a dois anos, sendo o pico de incidência abaixo de seis meses de vida. O quadro clínico consiste em sintomas de infecção de vias aéreas superiores, que evolui após dois a quatro dias com cansaço, dispneia, taquipneia, além de esforço respiratório. Febre e redução da aceitação da dieta também podem ocorrer. Apneia tem sido relatada em casos graves ou em prematuros. O diagnóstico baseia-se na história clínica e no exame físico, sendo exames complementares reservados quando há suspeita de outros diagnósticos ou de complicações. O tratamento é suportivo, sendo a oxigenoterapia indicada para pacientes com saturação de oxigênio abaixo de 90%. Atualmente, o corticoide oral não tem indicação no tratamento. Broncodilatadores não são indicados de rotina e o uso da salina hipertônica é controverso. O antiviral, ribavirina, tem indicação em casos específicos, devido aos efeitos adversos e ao alto custo. A profilaxia da BVA é fundamental, sendo a lavagem das mãos e o uso de álcool, de máscaras e de luvas essenciais para prevenção da doença. Como medicação profilática, o palivizumabe é indicado apenas em casos selecionados.(AU)


Acute bronchiolitis consists of a viral infection that affects children younger than 2 years old, with the peak of incidence under 6 months. The clinical disease has symptoms of infection of the upper airway, which develops after 2-4 days with fatigue, dyspnea, tachypnea, and respiratory effort. Fever and reduction of dietary compliance, may also occur. Apnea has been reported in severe cases or premature. The diagnosis is based on clinical history and physical examination, reserved additional tests when there is a suspicion of other diagnoses or complications. Treatment is supportive, the oxygen therapy is indicated for patients with oxygen saturation under 90%. Currently, oral corticosteroids has no indication for the treatment. The use of bronchodilators is not routinely indicated and the use of hypertonic saline is controversial. The use of the antiviral ribavirin is indicated in specific cases because there are adverse effects and high costs. Prophylaxis of bronchiolitis is fundamental, and hand-washing, use of alcohol, use of masks and gloves are essential for disease prevention. The use of palivizumab is indicated in selected cases.(AU)


Asunto(s)
Humanos , Terapia por Inhalación de Oxígeno , Bronquiolitis Viral/terapia , Ribavirina/uso terapéutico , Solución Salina Hipertónica/uso terapéutico , Broncodilatadores/uso terapéutico , Bronquiolitis Viral/prevención & control , Desinfección de las Manos/tendencias , Enfermedad Aguda , Palivizumab/uso terapéutico , Máscaras/tendencias
6.
Clinics ; 70(8): 577-583, 08/2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-753964

RESUMEN

OBJECTIVES: Hypertonic saline has been proposed to modulate the inflammatory cascade in certain experimental conditions, including pulmonary inflammation caused by inhaled gastric contents. The present study aimed to assess the potential anti-inflammatory effects of administering a single intravenous dose of 7.5% hypertonic saline in an experimental model of acute lung injury induced by hydrochloric acid. METHODS: Thirty-two pigs were anesthetized and randomly allocated into the following four groups: Sham, which received anesthesia and were observed; HS, which received intravenous 7.5% hypertonic saline solution (4 ml/kg); acute lung injury, which were subjected to acute lung injury with intratracheal hydrochloric acid; and acute lung injury + hypertonic saline, which were subjected to acute lung injury with hydrochloric acid and treated with hypertonic saline. Hemodynamic and ventilatory parameters were recorded over four hours. Subsequently, bronchoalveolar lavage samples were collected at the end of the observation period to measure cytokine levels using an oxidative burst analysis, and lung tissue was collected for a histological analysis. RESULTS: Hydrochloric acid instillation caused marked changes in respiratory mechanics as well as blood gas and lung parenchyma parameters. Despite the absence of a significant difference between the acute lung injury and acute lung injury + hypertonic saline groups, the acute lung injury animals presented higher neutrophil and tumor necrosis factor alpha (TNF-α), interleukin (IL)-6 and IL-8 levels in the bronchoalveolar lavage analysis. The histopathological analysis revealed pulmonary edema, congestion and alveolar collapse in both groups; however, the differences between groups were not significant. Despite the lower cytokine and neutrophil levels observed in the acute lung injury + hypertonic saline group, significant differences were not observed among the treated and non-treated groups. ...


Asunto(s)
Animales , Femenino , Lesión Pulmonar Aguda/tratamiento farmacológico , Antiinflamatorios/uso terapéutico , Solución Salina Hipertónica/uso terapéutico , Lesión Pulmonar Aguda/patología , Antiinflamatorios/farmacología , Recuento de Células Sanguíneas , Citocinas/análisis , Citocinas/efectos de los fármacos , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Ácido Clorhídrico , Hemodinámica/efectos de los fármacos , Neutrófilos/efectos de los fármacos , Distribución Aleatoria , Reproducibilidad de los Resultados , Porcinos , Solución Salina Hipertónica/farmacología , Factores de Tiempo , Resultado del Tratamiento
7.
Arq. neuropsiquiatr ; 73(6): 499-505, 06/2015. graf
Artículo en Inglés | LILACS | ID: lil-748186

RESUMEN

Traumatic brain injury (TBI) is the main cause of trauma-related deaths. Systemic hypotension and intracranial hypertension causes cerebral ischemia by altering metabolism of prostanoids. We describe prostanoid, pupilar and pathological response during resuscitation with hypertonic saline solution (HSS) in TBI. Method Fifteen dogs were randomized in three groups according to resuscitation after TBI (control group; lactated Ringer’s (LR) group and HSS group), with measurement of thromboxane, prostaglandin, macroscopic and microscopic pathological evaluation and pupil evaluation.Result Concentration of prostaglandin is greater in the cerebral venous blood than in plasma and the opposite happens with concentration of thromboxane. Pathology revealed edema in groups with the exception of group treated with HSS.Discussion and conclusion There is a balance between the concentrations of prostaglandin and thromboxane. HSS prevented the formation of cerebral edema macroscopically detectable. Pupillary reversal occurred earlier in HSS group than in LR group.


O traumatismo cranioencefálico (TCE) é a principal causa de morte relacionada ao trauma. O choque hemorrágico e hipertensão intracraniana causam isquemia cerebral alterando o metabolismo de prostanóides. Neste estudo, relatamos o comportamento dos prostanóides, resposta pupilar e patologia durante a reposição volêmica com solução salina hipertônica (SSH) no TCE. Método Quinze cachorros foram randomizados em três grupos (controle, grupo de Ringer lactato e grupo de SSH) e foram avaliados tromboxane, prostaglandina, avaliação patológica macroscópica e microscópica e status pupilar.Resultado A concentração de prostaglandina é maior no sangue cerebral em comparação ao plasma, e o inverso ocorre com o tromboxane. A patologia revelou edema em todos os grupos, com exceção do grupo tratado com SSH.Discussão e conclusão Existe um equilíbrio entre concentrações cerebrais e plasmáticas de prostaglandina e tromboxane. A SSH protegeu o cérebro da formação de edema pós traumático.


Asunto(s)
Animales , Perros , Masculino , Lesiones Encefálicas/tratamiento farmacológico , Fluidoterapia/métodos , Prostaglandinas F/sangre , Pupila/fisiología , Solución Salina Hipertónica/uso terapéutico , Choque Hemorrágico/terapia , Edema Encefálico/prevención & control , Lesiones Encefálicas/metabolismo , Encéfalo/metabolismo , Encéfalo/patología , Circulación Cerebrovascular/fisiología , Hemodinámica/fisiología , Presión Intracraneal , Soluciones Isotónicas/uso terapéutico , Distribución Aleatoria , Reproducibilidad de los Resultados , Choque Hemorrágico/metabolismo , Factores de Tiempo , Resultado del Tratamiento , /sangre
8.
São Paulo med. j ; 133(2): 166-167, Mar-Apr/2015.
Artículo en Inglés | LILACS | ID: lil-746655

RESUMEN

BACKGROUND: Patients with brain tumour usually suffer from increased pressure in the skull due to swelling of brain tissue. A swollen brain renders surgical removal of the brain tumour difficult. To ease surgical tumour removal, measures are taken to reduce brain swelling, often referred to as brain relaxation. Brain relaxation can be achieved with intravenous fluids such as mannitol or hypertonic saline. This review was conducted to find out which of the two fluids may have a greater impact on brain relaxation. OBJECTIVES: To compare the effects of mannitol versus those of hypertonic saline on intraoperative brain relaxation in patients undergoing craniotomy. METHODS: Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2013, Issue 10), Medline via Ovid SP (1966 to October 2013) and Embase via Ovid SP (1980 to October 2013). We also searched specific websites, such as www.indmed.nic.in, www.cochrane-sadcct.org and www.Clinicaltrials.gov. Selection criteria: We included randomized controlled trials (RCTs) that compared the use of hypertonic saline versus mannitol for brain relaxation. We also included studies in which any other method used for intraoperative brain relaxation was compared with mannitol or hypertonic saline. Primary outcomes were longest follow-up mortality, Glasgow Outcome Scale score at three months and any adverse events related to mannitol or hypertonic saline. Secondary outcomes were intraoperative brain relaxation, intensive care unit (ICU) stay, hospital stay and quality of life. Data collection and analysis: We used standardized methods for conducting a systematic review, as described by the Cochrane Handbook for Systematic Reviews of Interventions. Two review authors independently extracted details of trial methodology and outcome data from reports of all trials considered eligible for inclusion. All analyses were made on an intention-to-treat basis. We used a fixed-effect ...


Asunto(s)
Femenino , Humanos , Masculino , Neoplasias Encefálicas/cirugía , Craneotomía/métodos , Encefalitis/terapia , Soluciones Hipertónicas/uso terapéutico , Manitol/uso terapéutico , Solución Salina Hipertónica/uso terapéutico
9.
Acta cir. bras ; 29(11): 735-741, 11/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-728650

RESUMEN

PURPOSE: To evaluate intestinal inflammatory and apoptotic processes after intestinal ischemia/reperfusion injury, modulated by pentoxifylline and hypertonic saline. METHODS: It was allocated into four groups (n=6), 24 male Wistar rats (200 to 250g) and submitted to intestinal ischemia for 40 min and reperfusion for 80 min: IR (did not receive any treatment); HS group (Hypertonic Saline, 4ml/kg-IV); PTX group (Pentoxifylline, 30mg/kg-IV); HS+PTX group (Hypertonic Saline and Pentoxifylline). All animals were heparinized (100U/kg). At the end of reperfusion, ileal fragments were removed and stained on hematoxylin-eosin and histochemical studies for COX-2, Bcl-2 and cleaved caspase-3. RESULTS: The values of sO2 were higher on treated groups at 40 minutes of reperfusion (p=0.0081) and 80 minutes of reperfusion (p=0.0072). Serum lactate values were lower on treated groups after 40 minutes of reperfusion (p=0.0003) and 80 minutes of reperfusion (p=0.0098). Morphologic tissue injuries showed higher grades on IR group versus other groups: HS (p=0.0006), PTX (p=0.0433) and HS+PTX (p=0.0040). The histochemical study showed lesser expression of COX-2 (p=0.0015) and Bcl-2 (p=0.0012) on HS+PTX group. A lower expression of cleaved caspase-3 was demonstrated in PTX (p=0.0090; PTXvsIR). CONCLUSION: The combined use of pentoxifylline and hypertonic saline offers best results on inflammatory and apoptotic inhibitory aspects after intestinal ischemia/reperfusion. .


Asunto(s)
Animales , Masculino , Apoptosis/efectos de los fármacos , Intestinos/irrigación sanguínea , Isquemia/complicaciones , Pentoxifilina/farmacología , Inhibidores de Fosfodiesterasa/farmacología , Daño por Reperfusión/prevención & control , Solución Salina Hipertónica/farmacología , /análisis , /análisis , Inmunohistoquímica , Intestinos/efectos de los fármacos , Isquemia/prevención & control , Ácido Láctico/sangre , Oxígeno/metabolismo , Pentoxifilina/uso terapéutico , Inhibidores de Fosfodiesterasa/uso terapéutico , Ratas Wistar , Valores de Referencia , Reproducibilidad de los Resultados , Daño por Reperfusión/sangre , Solución Salina Hipertónica/uso terapéutico , Factores de Tiempo
10.
Braz. j. infect. dis ; 18(5): 518-525, Sep-Oct/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-723082

RESUMEN

Sepsis is one of the major causes of death and is the biggest obstacle preventing improvement of the success rate in curing critical illnesses. Currently, isotonic solutions are used in fluid resuscitation technique. Several studies have shown that hypertonic saline applied in hemorrhagic shock can rapidly increase the plasma osmotic pressure, facilitate the rapid return of interstitial fluid into the blood vessels, and restore the effective circulating blood volume. Here, we established a rat model of sepsis by using the cecal ligation and puncture approach. We found that intravenous injection of hypertonic saline dextran (7.5% NaCl/6% dextran) after cecal ligation and puncture can improve circulatory failure at the onset of sepsis. We found that the levels of tumor necrosis factor-α, interleukin-1β, interleukin-6 and intracellular adhesion molecule 1 levels in the lung tissue of cecal ligation and puncture rats treated with hypertonic saline dextran were significantly lower than the corresponding levels in the control group. We inferred that hypertonic saline dextran has a positive immunoregulatory effect and inhibits the overexpression of the inflammatory response in the treatment of sepsis. The percentage of neutrophils, lung myeloperoxidase activity, wet to dry weight ratio of lung tissues, histopathological changes in lung tissues, and indicators of arterial blood gas analysis was significantly better in the hypertonic saline dextran-treated group than in the other groups in this study. Hypertonic saline dextran-treated rats had significantly improved survival rates at 9 and 18 h compared to the control group. Our results suggest that hypertonic saline dextran plays a protective role in acute lung injury caused after cecal ligation and puncture. In conclusion, hypertonic/hyperoncotic solutions have beneficial therapeutic effects in the treatment of an animal model of sepsis.


Asunto(s)
Animales , Masculino , Lesión Pulmonar Aguda/prevención & control , Solución Salina Hipertónica/uso terapéutico , Sepsis/tratamiento farmacológico , Lesión Pulmonar Aguda/etiología , Lesión Pulmonar Aguda/patología , Modelos Animales de Enfermedad , Molécula 1 de Adhesión Intercelular/análisis , Interleucina-1beta/análisis , Interleucina-1beta/sangre , /análisis , Ratas Wistar , Sepsis/complicaciones , Factores de Tiempo , Factor de Necrosis Tumoral alfa/análisis
11.
Arch. argent. pediatr ; 111(4): 281-287, ago. 2013. ilus, tab
Artículo en Español | LILACS | ID: lil-694644

RESUMEN

Introducción. Las soluciones hipotónicas se han vinculado a la producción de hiponatremia iatrogénica. Objetivos. Evaluar las variaciones en el sodio sérico (NaS) tras la administración de una solución de mantenimiento intravenosa isotónica (NaCl al 0,9% en dextrosa al 5%) en comparación con una solución de mantenimiento hipotónica (NaCl al 0,45% en dextrosa al 5%). Material y métodos. Ensayo clínico aleatorizado, doble ciego y controlado. Se enrolaron pacientes pediátricos con una estadía esperada en la unidad de cuidados intensivos mayor de 24 horas, NaS normal y líquidos intravenosos > 80% de los líquidos totales de mantenimiento. La concentración sérica de Na se midió antes de colocar la solución de mantenimiento y al reducir la administración de ésta a < 80% del total del aporte. Resultados. Se incorporaron 63 pacientes, que fueron asignados en forma aleatoria a recibir una solución de mantenimiento hipotónica (n= 32) o isotónica (n= 31). Las características basales fueron similares en ambos grupos. No hubo diferencias con respecto a la cantidad de solución administrada (grupo hipotónico 865 ± 853 ml; grupo isotónico 778 ± 649 ml, p= 0,654) o el tiempo de infusión (grupo hipotónico: 24 ± 10,8 horas; grupo isotónico: 27,6 ± 12,8 horas, p= 0,231). Se encontró una diferencia en el NaS luego de la administración de las soluciones de mantenimiento (grupo hipotónico: 137,8 ± 4,3 mmol/L; grupo isotónico: 140,0 ± 4,1 mmol/L, p= 0,04). Ninguna de las dos soluciones de mantenimiento aumentó el riesgo de hiponatremia (Na 145 mmol/L). Conclusiones. Ambas soluciones de mantenimiento, en 24 horas de infusión, no aumentaron el riesgo de producir hiponatremia iatrogénica.


Introduction. Hypotonic fluids have been associated with the development of iatrogenic hyponatremia. Objectives. To assess variations in serum sodium (sNa) following the intravenous administration of isotonic maintenance fuids (0.9% NaCl/5% dextrose) compared to hypotonic maintenance fuids (0.45% NaCl/5% dextrose). Material and Methods. Randomized, controlled, double-blind clinical trial. Pediatric patients with an expected length of stay in the intensive care unit of more than 24 hours were enrolled, with normal serum Na, and IV fuids >80% of total maintenance fuids. Serum Na level was measured before administering maintenance fuids and when reducing the administration to <80% of total fuids. Results. The study included 63 patients who were randomly assigned to receive hypotonic (n= 32) or isotonic (n= 31) maintenance fuids. Baseline characteristics were similar in both groups. There were no differences in terms of volume of fuid administered (hypotonic group: 865 ± 853 mL; isotonic group: 778 ± 649 mL; p= 0.654) or infusion duration (hypotonic group: 24 ± 10.8 hours; isotonic group: 27.6 ± 12.8 hours; p= 0.231). A difference was found in the serum Na following the administration of maintenance fuids (hypotonic group: 137.8 ± 4.3 mmol/L; isotonic group: 140.0 ± 4.1 mmol/L, p= 0.04). None of these two maintenance fuids increased the risk of hyponatremia (Na 145 mmol/L). Conclusions. Neither hypotonic nor isotonic maintenance fluids increased the risk of developing iatrogenic hyponatremia with the 24 hour infusion.


Asunto(s)
Femenino , Humanos , Lactante , Masculino , Enfermedad Crítica/terapia , Cloruro de Sodio/administración & dosificación , Método Doble Ciego , Soluciones Hipotónicas/uso terapéutico , Infusiones Intravenosas , Estudios Prospectivos , Solución Salina Hipertónica/uso terapéutico , Cloruro de Sodio/uso terapéutico , Sodio/sangre
12.
Arch. argent. pediatr ; 111(4): 281-7, ago. 2013.
Artículo en Español | LILACS, BINACIS | ID: biblio-1159560

RESUMEN

INTRODUCTION: Hypotonic fluids have been associated with the development of iatrogenic hyponatremia. OBJECTIVES: To assess variations in serum sodium (sNa) following the intravenous administration of isotonic maintenance fluids (0.9


dextrose) compared to hypotonic maintenance fluids (0.45


dextrose). MATERIAL AND METHODS: Randomized, controlled, double-blind clinical trial. Pediatric patients with an expected length of stay in the intensive care unit of more than 24 hours were enrolled, with normal serum Na, and IV fluids >80


of total maintenance fluids. Serum Na level was measured before administering maintenance fluids and when reducing the administration to <80


of total fluids. RESULTS: The study included 63 patients who were randomly assigned to receive hypotonic (n= 32) or isotonic (n= 31) maintenance fluids. Baseline characteristics were similar in both groups. There were no differences in terms of volume of fluid administered (hypotonic group: 865 ± 853 mL; isotonic group: 778 ± 649 mL; p= 0.654) or infusion duration (hypotonic group: 24 ± 10.8 hours; isotonic group: 27.6 ± 12.8 hours; p= 0.231). A difference was found in the serum Na following the administration of maintenance fluids (hypotonic group: 137.8 ± 4.3 mmol/L; isotonic group: 140.0 ± 4.1 mmol/L, p= 0.04). None of these two maintenance fluids increased the risk of hyponatremia (Na 145 mmol/L). CONCLUSIONS: Neither hypotonic nor isotonic maintenance fluids increased the risk of developing iatrogenic hyponatremia with the 24 hour infusion.


Asunto(s)
Cloruro de Sodio/administración & dosificación , Enfermedad Crítica/terapia , Cloruro de Sodio/uso terapéutico , Estudios Prospectivos , Femenino , Humanos , Infusiones Intravenosas , Lactante , Masculino , Método Doble Ciego , Solución Salina Hipertónica/uso terapéutico , Soluciones Hipotónicas/uso terapéutico , Sodio/sangre
13.
Clinics ; 68(6): 883-886, jun. 2013.
Artículo en Inglés | LILACS | ID: lil-676943

RESUMEN

The objectives of this review are to assess the current state of hypertonic saline as a prehospital resuscitation fluid in hypotensive trauma patients, particularly after the 3 major Resuscitation Outcomes Consortium trauma trials in the US and Canada were halted due to futility. Hemorrhage and traumatic brain injury are the leading causes of death in both military and civilian populations. Prehospital fluid resuscitation remains controversial in civilian trauma, but small-volume resuscitation with hypertonic fluids is of utility in military scenarios with prolonged or delayed evacuation times. A large body of pre-clinical and clinical literature has accumulated over the past 30 years on the hemodynamic and, most recently, the anti-inflammatory properties of hypertonic saline, alone or with dextran-70. This review assesses the current state of hypertonic fluid resuscitation in the aftermath of the failed Resuscitation Outcomes Consortium trials.


Asunto(s)
Humanos , Ensayos Clínicos como Asunto , Servicios Médicos de Urgencia/métodos , Resucitación/métodos , Solución Salina Hipertónica/uso terapéutico , Lesiones Encefálicas/terapia , Canadá , Choque Hemorrágico/terapia , Estados Unidos
14.
Korean Journal of Radiology ; : 232-236, 2012.
Artículo en Inglés | WPRIM | ID: wpr-112465

RESUMEN

Primary pancreatic hydatid cysts are rare and its percutaneous treatment and catheterization technique has, to the best of our knowledge, not been published in literature. A 33-year-old male patient who presented with abdominal pain was evaluated by ultrasonography (US) and computed tomography examinations. Both examinations revealed a cyst in the neck of the pancreas. After the administration of albendazole chemoprophylaxis, the patient underwent diagnostic puncture showing high pressure spring water which harbored the scoleces and was treated percutaneously by the catheterization technique. In this technique, first the cyst was punctured, the fluid content aspirated, the radiocontrast material injected to see possible fistulisation, and then re-aspirated. The 20% hypertonic saline solution was injected and re-aspiration was performed to the best of our abilities, followed by the insertion of a catheter for drainage of the remaining non-aspiratable fluid content. At follow-up examination, the cyst was not visible on US after 6 months. There was no evidence of cyst recurrence or dissemination after 18 months at serologic and imaging follow-up.


Asunto(s)
Adulto , Humanos , Masculino , Albendazol/uso terapéutico , Antihelmínticos/uso terapéutico , Drenaje , Equinococosis/diagnóstico por imagen , Enfermedades Pancreáticas/parasitología , Punciones , Solución Salina Hipertónica/uso terapéutico , Tomografía Computarizada por Rayos X
16.
Mediciego ; 17(1)mar. 2011. ilus
Artículo en Español | LILACS | ID: lil-616704

RESUMEN

Se presenta el caso de un lactante masculino de 6 meses de edad, que acude a consulta de cuerpo de guardia, en el Hospital Provincial Docente Dr Antonio Luaces Iraola de Ciego de Ávila, con vómitos y diarreas con estrías de sangre. Se realizaron estudios ecográficos pertinentes y se arribó al diagnóstico de invaginación intestinal. Se realizó evaluación conjunta con el servicio de cirugía pediátrica y se aplicó el proceder de reducción hidrostática con solución salina y control ecográfico, con lo que se logró la reducción total del segmento intestinal afectado y se evitó la intervención quirúrgica.


A case of a male infant of 6 months of age is presented, that goes to consultation of emergency service, in the Provincial Teaching Hospital in Ciego de Avila with vomiting and diarrhea streaked of blood. Relevant ultrasonography studies were carried out and it arrived to diagnosis of intussusception. Joint assessment was conducted with the pediatric surgery department, and hydrostatic reduction applies with saline solution and ultrasonographic guidance, achieving a total reduction of the affected bowel segment, thus avoiding surgery.


Asunto(s)
Humanos , Masculino , Lactante , Intususcepción/terapia , Intususcepción , Solución Salina Hipertónica/uso terapéutico
19.
Clinics ; 65(6): 621-628, 2010. ilus
Artículo en Inglés | LILACS | ID: lil-553968

RESUMEN

INTRODUCTION: Combining the hemodynamic and immune benefits of hypertonic saline with the anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline (HSPTX) as a hemorrhagic shock resuscitation strategy reduces lung injury when compared with the effects of Ringer's lactate (RL). We hypothesized that HSPTX exerts its anti-inflammatory effects by interfering with nuclear factor kappa B/cAMP response element-binding protein (NF-êB-CREB) competition for the coactivator CREB-binding protein (CBP) in lung tissue, thus affecting pro-inflammatory mediator production. METHODS: Male Sprague-Dawley rats underwent 60 minutes of hemorrhagic shock to reach a mean arterial blood pressure of 35 mmHg followed by resuscitation with either RL or HSPTX (7.5 percent HS + 25 mg/kg PTX). After four hours, lung samples were collected. NF-êB activation was assessed by measuring the levels of phosphorylated cytoplasmic inhibitor of kappa B (I-êB) and nuclear NF-êB p65 by western blot. NF-êB and CREB DNA-binding activity were measured by electrophoretic mobility shift assay (EMSA). Competition between NF-êB and CREB for the coactivator CBP was determined by immunoprecipitation. Interleukin-8 (IL-8) levels in the lung were measured by ELISA. RESULTS: RL resuscitation produced significantly higher levels of lung IL-8 levels, I-êB phosphorylation, p65 phosphorylation, and NF-êB DNA binding compared with HSPTX. NF-êB-CBP-binding activity was similar in both groups, whereas CREB-CBP-binding activity was significantly increased with HSPTX. CREB-DNA binding-activity increased to a greater level with HSPTX compared with RL. DISCUSSION: HSPTX decreases lung inflammation following hemorrhagic shock compared with conventional resuscitation using RL through attenuation of NF-êB signaling and increased CREB-DNA binding activity. HSPTX may have therapeutic potential in the attenuation of ischemia-reperfusion...


Asunto(s)
Animales , Masculino , Ratas , Mediadores de Inflamación/metabolismo , Pulmón/metabolismo , Inhibidores de Fosfodiesterasa/uso terapéutico , Choque Hemorrágico/terapia , Factores de Transcripción/metabolismo , Antiinflamatorios/uso terapéutico , Modelos Animales de Enfermedad , Pulmón/patología , FN-kappa B/metabolismo , Proteínas Nucleares/metabolismo , Pentoxifilina/uso terapéutico , Ratas Sprague-Dawley , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/metabolismo , Resucitación/métodos , Solución Salina Hipertónica/uso terapéutico , Choque Hemorrágico/complicaciones , Choque Hemorrágico/metabolismo
20.
Clinics ; 65(1): 67-78, 2010. ilus, graf
Artículo en Inglés | LILACS | ID: lil-538609

RESUMEN

Objetive: This study evaluated retroperitoneal hematomas produced by bilateral injury of iliac arteries (uncontrolled hemorrhage), blood volume loss, transcapillary refill, the effects of volume replacement on retroperitoneal bleeding and the hemodynamic changes with and without treatment. Methods: Initial blood volume was determined with Tc99m-labelled red cells, and bleeding was evaluated by means of a portable scintillation camera positioned over the abdomen. Previously splenectomized mongrel dogs (16.8 ± 2.2 kg) were submitted to hemorrhage for 30 minutes and randomized into three groups: I - no treatment (n=7); II - treatment with 32 mL/kg of Lactated Ringer's for three to five minutes (n=7); and III - treatment with 4 mL/kg of 7.5 percent NaCl plus 6.0 percent dextran 70 for three to five minutes (n=7). They were studied for an additional 45 minutes. Results: Volume replacement produced transitory recovery in hemodynamic variables, including mean pulmonary artery pressure, pulmonary capillary wedge pressure and cardiac index, with significant increase in dogs treated with 32 mL/kg of Lactated Ringer's and 7.5 percent NaCl plus 6.0 percent dextran 70 (p<0.001, against no treatment), along with a decrease (p<0.001) in the systemic vascular resistance index. Groups II and III had significant initial decreases in hematocrit and hemoglobin. The treated dogs (groups II and III) presented rebleeding, which was greater during treatment with 32 mL/kg of Lactated Ringer's (group II). Conclusions: Despite the rebleeding observed in treated groups, the utilization of hypertonic saline solution with dextran proved to be effective in the initial reanimation, producing evident transcapillary refill, while the Lactated Ringer's solution produced capillary extravasation and was ineffective in the initial volume replacement in this model of uncontrolled hemorrhage.


Asunto(s)
Animales , Perros , Masculino , Volumen Sanguíneo/efectos de los fármacos , Dextranos/uso terapéutico , Fluidoterapia/métodos , Hemorragia Gastrointestinal/tratamiento farmacológico , Hematoma/tratamiento farmacológico , Análisis de Varianza , Capilares/efectos de los fármacos , Modelos Animales de Enfermedad , Fluidoterapia/normas , Hemorragia Gastrointestinal/fisiopatología , Hematoma/fisiopatología , Hemodinámica/efectos de los fármacos , Arteria Ilíaca/lesiones , Soluciones Isotónicas/uso terapéutico , Distribución Aleatoria , Espacio Retroperitoneal/irrigación sanguínea , Solución Salina Hipertónica/uso terapéutico , Choque Hemorrágico/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA